#Donanemab

Live, measured metrics for the hashtag #Donanemab from the open social web. Every number carries a named source and the time it was fetched. Nothing is estimated.

hashtag.org network · sponsored

Own #donanemab

This #name is available to claim. It becomes your portal on the open agent web: this very page, a keyword you rank for by an open public stake, and a verifiable identity for AI agents. Nobody else sells a page like this for every #name.

$51.02/ year · 9-character #name
Claim #donanemab — $51.02/yr→Buy on hashtag.space (web3)
card via hashtag.org · tokens via hashtag.space
1
Uses / 7 days
Mastodon
1
Accounts / 7 days
Mastodon
31
Recent posts
Mastodon
~0/hr
Recent pace
Mastodon · last 31
0
Avg reactions / post
Mastodon · last 31
—
Reddit posts / month
Reddit search
—
Open-web mentions
hashtag.org Firehose

Day-by-day usage

measured · mastodon.online (Mastodon public tags API) · fetched 2026-09-25 18:56 UTC
0
09-19
0
09-20
1
09-21
0
09-22
0
09-23
0
09-24
0
09-25

1 uses by 1 unique accounts across the window. Real per-day counts, not estimates. Newest bar is today so far.

Related hashtags

measured · mastodon.online (Mastodon public search API) · fetched 2026-09-25 18:56 UTC

No related tags with measured usage found for #donanemab.

Live pulse

measured · mastodon.online (Mastodon tag timeline) · fetched 2026-09-25 18:56 UTC

Everything below is measured over the latest 31 public posts (spanning ~29670 hours).

Posting hours (UTC) — busiest: 11:00

00:0012:0023:00

Languages: English (18) · German (9) · Finnish (3) · Italian (1)

Avg boosts / post: 1.2

Top of the latest posts

  • Clinical trials for the treatment of Alzheimer's disease continue to face a global shortage of participants despite the arrival of new drugs and treatments, a trend that could slow progress in dementia therapies. https://www.japantimes.co.j

    The Japan Times@[email protected]♥ 0↻ 22026-09-21 00:43 UTCView post →
  • #Donanemab ist seit November 2025 in Deutschland zur Behandlung der frühen #Alzheimer-Demenz verfügbar. Der Antikörper soll den Krankheitsverlauf verlangsamen. Doch wie groß ist der Nutzen tatsächlich und welche Risiken bringt die Behandlun

    Gute Pillen – Schlechte Pillen@[email protected]♥ 0↻ 22026-09-18 07:30 UTCView post →
  • A team of scientists in Japan has identified the "seed" of a protein believed to trigger Alzheimer's disease, a discovery boosting hope for the development of a new therapy for the neurodegenerative condition. https://www.japantimes.co.jp/n

    The Japan Times@[email protected]♥ 0↻ 82026-07-21 11:56 UTCView post →

What “donanemab” means

Wikipedia

Donanemab, sold under the brand name Kisunla, is a monoclonal antibody used for the treatment of Alzheimer's disease. Donanemab was developed by Eli Lilly and Company.

“Donanemab” on Wikipedia (CC BY-SA) →

#donanemab across platforms

every network with a public tag surface

Follow #donanemab straight to each platform’s own tag page. Where a platform publishes open data we measure it above; the rest lock their numbers behind paid APIs, so we link rather than guess.

Every number above is measured from a named public API at the shown fetch time. Nothing is estimated or extrapolated. Platforms that lock their data behind paid APIs are not shown. Agents: the same numbers, as JSON, at /api/hashtags/donanemab